OS
68.8%
(5y)
71.1%
93.0%
(1y)
80.5%
(3y)
85.2%
73.3%
Overall Survival
al
Event-Free Survival
Nicolai et al, Head Neck 2015
ADENOCARCINOMA
mercoledì 29 giugno 16